Engrave Wealth Partners LLC Bristol Myers Squibb CO Transaction History

Engrave Wealth Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$68.48 - $81.09 $15,544 - $18,407	227 Added 7.97%	3,076 $0
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $508 - $559	7 Added 0.25%	2,849 $219,000
Q1 2022 Apr 19, 2022	BUY	$61.48 - $73.72 $174,726 - $209,512	2,842 New	2,842 $208,000
Q3 2021 Oct 08, 2021	SELL	$59.17 - $69.31 $252,951 - $296,300	-4,275 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $8,605 - $9,371	139 Added 3.36%	4,275 $286,000
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $14,360 - $16,151	242 Added 6.21%	4,136 $261,000
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $224,839 - $254,784	3,894 New	3,894 $252,000
Q3 2020 Oct 08, 2020	SELL	$57.43 - $63.64 $193,711 - $214,657	-3,373 Closed	0 $0
Q4 2019 Mar 12, 2020	BUY	$49.21 - $64.19 $165,985 - $216,512	3,373 New	3,373 $216,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Engrave Wealth Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Engrave Wealth Partners LLC with notifications on news.